ConductScience.org, home

Paper41301019

Integrating PET and MRI Radiomics for Staging and Prognostic Stratification in Anal Canal Cancer.

Murad V and 6 others. Cancers (Basel), 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Integrating PET and MRI Radiomics for Staging and Prognostic Stratification in Anal Canal Cancer. Papers, record 41301019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301019

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Integrating PET and MRI Radiomics for Staging and Prognostic Stratification in Anal Canal Cancer.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-11-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Murad VVanessa
2Kohan AAndres
3Avery LLisa
4Ortega CClaudia
5Mesci AAruzhttps://orcid.org/0000-0002-8327-794X
6Veit-Haibach PPatrick
7Metser UUrhttps://orcid.org/0000-0003-3726-8994

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References31

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123882093Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure.Radiology2013https://conductscience.org/library/papers/23882093PubMed
237592085[18F]-FDG PET in anal canal cancer: a systematic review and meta-analysis.Eur J Nucl Med Mol Imaging2023https://conductscience.org/library/papers/37592085PubMed
327895266A simple method to estimate the time-dependent receiver operating characteristic curve and the area under the curve with right censored data.Stat Methods Med Res2018https://conductscience.org/library/papers/27895266PubMed
435274187Combined PET-CT and MRI for response evaluation in patients with squamous cell anal carcinoma treated with curative-intent chemoradiotherapy.Eur Radiol2022https://conductscience.org/library/papers/35274187PubMed
529878949The American Society of Colon and Rectal Surgeons Clinical Practice Guidelines for Anal Squamous Cell Cancers (Revised 2018).Dis Colon Rectum2018https://conductscience.org/library/papers/29878949PubMed
640049747[18F]-FDG PET/CT in the Initial Staging of Squamous Cell Cancer of the Anal Canal: Results of a Prospective Multicenter Registry.J Nucl Med2025https://conductscience.org/library/papers/40049747PubMed
731482428Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT.Eur J Nucl Med Mol Imaging2019https://conductscience.org/library/papers/31482428PubMed
833509369Radiomics in PET/CT: Current Status and Future AI-Based Evolutions.Semin Nucl Med2021https://conductscience.org/library/papers/33509369PubMed
930339668Anal cancer in high-income countries: Increasing burden of disease.PLoS One2018https://conductscience.org/library/papers/30339668PubMed
1032060219Introduction to Radiomics.J Nucl Med2020https://conductscience.org/library/papers/32060219PubMed
1133430396MRI-Based Radiomics Input for Prediction of 2-Year Disease Recurrence in Anal Squamous Cell Carcinoma.Cancers (Basel)2021https://conductscience.org/library/papers/33430396PubMed
1221822946Tumour ADC measurements in rectal cancer: effect of ROI methods on ADC values and interobserver variability.Eur Radiol2011https://conductscience.org/library/papers/21822946PubMed
1329759568Positron emission tomography and computed tomographic (PET/CT) imaging for radiation therapy planning in anal cancer: A systematic review and meta-analysis.Crit Rev Oncol Hematol2018https://conductscience.org/library/papers/29759568PubMed
1434175386Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆.Ann Oncol2021https://conductscience.org/library/papers/34175386PubMed
1531005205MRI heterogeneity analysis for prediction of recurrence and disease free survival in anal cancer.Radiother Oncol2019https://conductscience.org/library/papers/31005205PubMed
1629089827Cancer of the Anal Canal: Diagnosis, Staging and Follow-Up with MRI.Korean J Radiol2017https://conductscience.org/library/papers/29089827PubMed
1723580899Anal cancer - a review.Int J Health Sci (Qassim)2012https://conductscience.org/library/papers/23580899PubMed
1835020204Cancer statistics, 2022.CA Cancer J Clin2022https://conductscience.org/library/papers/35020204PubMed
1937972216Radiomics; Contemporary Applications in the Management of Anal Cancer; A Systematic Review.Am Surg2024https://conductscience.org/library/papers/37972216PubMed
2030694160Validation of A Method to Compensate Multicenter Effects Affecting CT Radiomics.Radiology2019https://conductscience.org/library/papers/30694160PubMed

See all 31 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41301019

GET https://conductscience.org/api/papers/v1/41301019/references?page=2